O
OOVA
OOVA is a fertility diagnostic company that brings the accuracy of a clinic into your own home
About OOVA
Oova, a fertility tech company, was founded in 2017 by Aparna Divaraniya and Jerome Scelza. The company provides an at-home fertility tracking platform that helps women monitor their hormone levels with lab-grade accuracy.
The founders' backgrounds are complementary to the company's mission. Divaraniya has a Ph.D. in biomedical engineering and Scelza has experience in business development and marketing. Their combined expertise has been instrumental in developing and commercializing Oova's product.
Oova's business model is direct-to-consumer. The company sells its fertility kit directly to women through its website. The kit includes a set of urine test strips and a smartphone app. The app uses a proprietary algorithm to analyze the test results and provide personalized insights and recommendations.
The Oova kit measures two key fertility hormones: luteinizing hormone (LH) and progesterone. LH is a key predictor of ovulation, while progesterone confirms that ovulation has occurred. By tracking these two hormones, Oova provides a complete picture of a woman's fertile window.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Town of Babylon, United States
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 62.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Consumer Goods, Fertility, Women's Health, Health Diagnostics, Spinout, Femtech, Reproductive Health, Woman Founder, DT and LS, science-based
- Technology
- Deep Tech
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jun 2023 | $10M | $41M | Connecticut Innovations · US Fertility · Virgin Group · Spero Ventures | ↗ |
| SEEDOther financing | Jul 2021 | $1.2M | $4.8M | Company Ventures · BBG Ventures | — |
Growth signals
Latest recorded traffic for OOVA is 64K monthly website visits, up 28% over the last three months. OOVA's team declined 20.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Company Ventures
Thorne
Amplifyher Ventures- TFThe Living Fund
Women Who Tech
BBG Ventures
Series A5 investors entered at this stage
Connecticut Innovations
US Fertility
Virgin Group
Spero Ventures
Jefferson Health System
Other known investors3 additional known investors
Burst Capital
For Good Ventures
Kluz Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about OOVA on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OOVA’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.